ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - metformin hydrochloride 850 mg - tablets - metformin - metformin teva is indicated in diet - failed non - insulin dependent diabetic patients especially if overweight either alone as initial therapy or in combination with a sulfonylurea. occasionally as adjuvant therapy in insulin - dependent diabetic patients particularly who are usually obese and not well controlled with insulin.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - metformin hydrochloride 850 mg - tablets - metformin - metformin teva is indicated in diet - failed non - insulin dependent diabetic patients especially if overweight either alone as initial therapy or in combination with a sulfonylurea. occasionally as adjuvant therapy in insulin - dependent diabetic patients particularly who are usually obese and not well controlled with insulin.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - metformin hydrochloride 850 mg - tablets - metformin - metformin teva is indicated in diet - failed non - insulin dependent diabetic patients especially if overweight either alone as initial therapy or in combination with a sulfonylurea. occasionally as adjuvant therapy in insulin - dependent diabetic patients particularly who are usually obese and not well controlled with insulin.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - tocopherol (vit e) (as tocopheryl acetate) - טבליה - tocopherol (vit e) (as tocopheryl acetate) 100 mg - tocopherol (vit e) - tocopherol (vit e) - for the prevention and treatment of diseases caused by vitamin e deficiency.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - tocopherol (vit e) (as tocopheryl acetate) - טבליה - tocopherol (vit e) (as tocopheryl acetate) 200 mg - tocopherol (vit e) - tocopherol (vit e) - for the prevention and treatment of diseases caused by vitamin e deficiency.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - tocopherol (vit e) (as tocopheryl acetate) - טבליה - tocopherol (vit e) (as tocopheryl acetate) 200 mg - tocopherol (vit e) - tocopherol (vit e) - for the prevention and treatment of diseases caused by vitamin e deficiency.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - eptifibatide 2 mg/ml - solution for injection - eptifibatide - eptifibatide teva is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-q-wave myocardial infarction. eptifibatide is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. eptifibatide is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (ptca) balloon angioplasty directional atheretomy transluminal extraction catheter atherectomy rotational ablation angioplasty or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death myorardial infarction need for urgent intervention). eptifibatide is intended for use with aspirin and heparin.

ישראל - עברית - Ministry of Health

teva israel ltd - tranexamic acid - טבליה - tranexamic acid 500 mg - tranexamic acid - tranexamic acid - treatment of hemorrhage occuring in some forms of surgery, including prostatectomy. hematuria. menorrhagia. hereditary angioneurotic edema.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - furosemide - טבליה - furosemide 40 mg - furosemide - furosemide - edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. adjunctive therapy in acute pulmonary edema. treatment of hypertension.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - spironolactone - טבליה - spironolactone 25 mg - spironolactone - spironolactone - edematous conditions: - congestive heart failure; - cirrosis of the liver accompanied by edema and/or ascites nephrotic syndrome. essential hypertention. primary hyperaldostronism. hypokalemia.